COVID-19: Hydroxychloroquine has no meaningful effect on deaths or hospitalisations ─WHO

*The World Health Organisation’s expert panel has discovered that Hydroxychloroquine had no meaningful effect on deaths or hospitalisations, and may even intensify the risk of adverse effects on consumers

Isola Moses | ConsumerConnect

Though much touted as preventive medicine against the novel Coronavirus (COVID-19) pandemic by former United States President Donald Trump, the World Health Organisation (WHO) expert panel has clarified that anti-inflammatory drug Hydroxychloroquine should not be used in efforts at prevent infection with the damaging virus.

A UN health body’s expert panel found that the medicine had no meaningful effect on deaths or hospitalisations, and may even increase the risk of adverse effects, the group said in a statement Tuesday.

Recall in 2020, that the medicine was publicised as a COVID-19 treatment by former President Trump, but was later deemed ineffective.

The US Food and Drug Administration (FDA) revoked its authorisation after just a few months when research showed the drug did not work against the virus.

According to WHO, its recommendation is based on evidence from six randomised controlled trials with more than 6,000 participants with or without known exposure to a person with Covid-19.

Hydroxychloroquine, therefore, is no longer considered a research priority and resources should be used to evaluate other promising preventive drugs, said WHO.

Kindly Share This Story